Cargando…
Minimax and admissible adaptive two-stage designs in phase II clinical trials
BACKGROUND: Simon’s two-stage design is the most widely implemented among multi-stage designs in phase II clinical trials to assess the activity of a new treatment in a single-arm study. In this two-stage design, the sample size from the second stage is fixed regardless of the number of responses ob...
Autores principales: | Shan, Guogen, Zhang, Hua, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969653/ https://www.ncbi.nlm.nih.gov/pubmed/27485595 http://dx.doi.org/10.1186/s12874-016-0194-3 |
Ejemplares similares
-
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
por: Qin, Fei, et al.
Publicado: (2020) -
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
por: Kim, Jongphil, et al.
Publicado: (2019) -
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
por: Shan, Guogen, et al.
Publicado: (2017) -
Restricted parameter space estimation problems: admissibility and minimaxity properties
por: van Eeden, Constance
Publicado: (2006) -
Minimax and applications
por: Du, Ding-Zhu, et al.
Publicado: (1995)